Welichem Biotech Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Welichem Biotech General Information
Description
Developer of therapeutic drugs intended for autoimmune diseases. The company is engaged in the discovery and development of small molecule therapeutics, thereby enabling its clients to be provided with quality products at a competitive price.
Contact Information
Website
www.welichem.comCorporate Office
- 4475 Wayburne Drive
- Suite 316
- Burnaby, British Columbia V5G 3L1
- Canada
Corporate Office
- 4475 Wayburne Drive
- Suite 316
- Burnaby, British Columbia V5G 3L1
- Canada
Welichem Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 22-Jul-2014 | Completed | Generating Revenue | |||
| 2. IPO | 25-May-2005 | Completed | Generating Revenue | |||
| 1. Angel (individual) | 01-May-2005 | $1.9M | $1.9M | Completed | Generating Revenue |
Welichem Biotech Patents
Welichem Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2628459-T3 | Novel sulfonamide compounds for growth inhibition of metastatic tumors | Active | 09-Jul-2010 | ||
| JP-5918227-B2 | Novel sulfonamide compounds for inhibiting the growth of metastatic tumors | Active | 09-Jul-2010 | ||
| CA-2841217-A1 | Novel sulfonamide compounds for inhibition of metastatic tumor growth | Active | 09-Jul-2010 | ||
| CA-2841217-C | Novel sulfonamide compounds for inhibition of metastatic tumor growth | Active | 09-Jul-2010 | ||
| EP-2590938-A1 | Novel sulfonamide compounds for inhibition of metastatic tumor growth | Active | 09-Jul-2010 | A61K31/63 |
Welichem Biotech Signals
Welichem Biotech Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedInnova Partners | Venture Capital | Minority | ||
| WUTIF Capital | Angel Group | Minority |
Welichem Biotech FAQs
-
When was Welichem Biotech founded?
Welichem Biotech was founded in 1995.
-
Where is Welichem Biotech headquartered?
Welichem Biotech is headquartered in Burnaby, Canada.
-
What is the size of Welichem Biotech?
Welichem Biotech has 4 total employees.
-
What industry is Welichem Biotech in?
Welichem Biotech’s primary industry is Pharmaceuticals.
-
Is Welichem Biotech a private or public company?
Welichem Biotech is a Private company.
-
What is Welichem Biotech’s current revenue?
The current revenue for Welichem Biotech is .
-
How much funding has Welichem Biotech raised over time?
Welichem Biotech has raised $1.9M.
-
Who are Welichem Biotech’s investors?
MedInnova Partners and WUTIF Capital have invested in Welichem Biotech.
-
When was Welichem Biotech acquired?
Welichem Biotech was acquired on 22-Jul-2014.
-
Who acquired Welichem Biotech?
Welichem Biotech was acquired by LJ Resources.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process